Dupont Capital Management Corp Pacira Bio Sciences, Inc. Transaction History

Dupont Capital Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 29, 2020	SELL	$28.4 - $50.7 $728,857 - $1.3 Million	-25,664 Closed	0 $0
Q3 2019 Oct 28, 2019	BUY	$35.66 - $44.99 $915,178 - $1.15 Million	25,664 New	25,664 $977,000
Q4 2017 Jan 31, 2018	SELL	$31.85 - $46.95 $480,616 - $708,475	-15,090 Closed	0 $0
Q3 2017 Oct 31, 2017	BUY	$35.7 - $39.5 $538,713 - $596,055	15,090	15,090 $567,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.